Xiaoping Wu

1.8k total citations
81 papers, 1.4k citations indexed

About

Xiaoping Wu is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Xiaoping Wu has authored 81 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 20 papers in Cancer Research and 18 papers in Cell Biology. Recurrent topics in Xiaoping Wu's work include Fibroblast Growth Factor Research (25 papers), Proteoglycans and glycosaminoglycans research (12 papers) and Cancer, Hypoxia, and Metabolism (9 papers). Xiaoping Wu is often cited by papers focused on Fibroblast Growth Factor Research (25 papers), Proteoglycans and glycosaminoglycans research (12 papers) and Cancer, Hypoxia, and Metabolism (9 papers). Xiaoping Wu collaborates with scholars based in China, Hong Kong and United States. Xiaoping Wu's co-authors include Xiaokun Li, Jianzhang Wu, Jingjing Li, Youhua Wu, Shuwen Deng, Xiaohua Hu, Jinming Zhang, Xuyu Zu, Fengxiang Yan and Gph Leung and has published in prestigious journals such as Blood, PLoS ONE and Nature Cell Biology.

In The Last Decade

Xiaoping Wu

78 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoping Wu China 22 864 237 185 173 137 81 1.4k
Shanmin Yang United States 21 790 0.9× 179 0.8× 168 0.9× 174 1.0× 90 0.7× 54 1.6k
Jun‐Jen Liu Taiwan 23 783 0.9× 205 0.9× 181 1.0× 160 0.9× 62 0.5× 49 1.6k
Binghui Li China 23 1.2k 1.4× 288 1.2× 196 1.1× 134 0.8× 114 0.8× 54 1.8k
Lisa C. Crowley Australia 15 909 1.1× 217 0.9× 206 1.1× 204 1.2× 81 0.6× 19 1.8k
Yi‐Ping Huang Taiwan 27 1.2k 1.4× 401 1.7× 342 1.8× 127 0.7× 85 0.6× 100 2.0k
Cheng Luo China 28 1.2k 1.4× 310 1.3× 147 0.8× 348 2.0× 110 0.8× 95 2.6k
Chenglai Xia China 24 691 0.8× 267 1.1× 193 1.0× 183 1.1× 69 0.5× 61 1.4k
Eleonora Turrini Italy 24 815 0.9× 202 0.9× 260 1.4× 87 0.5× 65 0.5× 62 2.0k
Xiaohui Yan China 20 894 1.0× 320 1.4× 161 0.9× 100 0.6× 57 0.4× 62 1.6k

Countries citing papers authored by Xiaoping Wu

Since Specialization
Citations

This map shows the geographic impact of Xiaoping Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Wu more than expected).

Fields of papers citing papers by Xiaoping Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoping Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Wu. The network helps show where Xiaoping Wu may publish in the future.

Co-authorship network of co-authors of Xiaoping Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoping Wu. A scholar is included among the top collaborators of Xiaoping Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoping Wu. Xiaoping Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Xiaoping, Shawn Fayer, Alan F. Rubin, et al.. (2025). Multiplex and multimodal mapping of variant effects in secreted proteins via MultiSTEP. Nature Structural & Molecular Biology. 32(10). 2099–2111. 2 indexed citations
2.
Yang, Xiaohua, Qingqing Liu, & Xiaoping Wu. (2025). Meta-Analysis of the Clinical Efficacy of Auricular Acupressure on Patients with Depression. ALPHA PSYCHIATRY. 26(1). 38776–38776.
3.
Tan, Yeru, Baohong Jiang, Wenjie Feng, et al.. (2024). Circ0060467 sponges miR-6805 to promote hepatocellular carcinoma progression through regulating AIFM2 and GPX4 expression. Aging. 16(2). 1796–1807. 14 indexed citations
4.
Li, Jingjing, Xi‐Qiao Feng, Yihan Wu, et al.. (2024). Taohong Siwu decoction enhances the chemotherapeutic efficacy of doxorubicin by promoting tumor vascular normalization. Phytomedicine. 134. 155995–155995. 3 indexed citations
5.
Nie, Xin, Jingjing Li, Yanfen Cheng, et al.. (2024). Characterization of a polysaccharide from Amauroderma rugosum and its proangiogenic activities in vitro and in vivo. International Journal of Biological Macromolecules. 271(Pt 2). 132533–132533. 6 indexed citations
7.
Nie, Xin, Li Fu, Yanfen Cheng, et al.. (2023). Garcinone E suppresses breast cancer growth and metastasis by modulating tumor‐associated macrophages polarization via STAT6 signaling. Phytotherapy Research. 37(10). 4442–4456. 17 indexed citations
8.
Hu, Xiaohua, Xiaoping Wu, Kalen Berry, et al.. (2023). Nuclear condensates of YAP fusion proteins alter transcription to drive ependymoma tumourigenesis. Nature Cell Biology. 25(2). 323–336. 36 indexed citations
9.
Yang, Kangmin, Srividya Velagapudi, Alexander Akhmedov, et al.. (2023). Chronic SIRT1 supplementation in diabetic mice improves endothelial function by suppressing oxidative stress. Cardiovascular Research. 119(12). 2190–2201. 24 indexed citations
10.
Huang, Han-Ying, Yang Li, Yang Liu, et al.. (2023). A new autophagy-related nomogram and mechanism in multiple myeloma. Genes & Diseases. 11(5). 101120–101120. 1 indexed citations
11.
Cheng, Yanfen, Xuemei Zhong, Huan Gu, et al.. (2023). Glycyrrhetinic acid suppresses breast cancer metastasis by inhibiting M2-like macrophage polarization via activating JNK1/2 signaling. Phytomedicine. 114. 154757–154757. 42 indexed citations
12.
Zeng, Xiangfeng, et al.. (2023). AMIGO2 attenuates innate cisplatin sensitivity by suppression of GSDME‐conferred pyroptosis in non‐small cell lung cancer. Journal of Cellular and Molecular Medicine. 27(16). 2412–2423. 10 indexed citations
13.
Cheng, Yanfen, Xiaoping Wu, Yihan Wu, et al.. (2022). Natural compound glycyrrhetinic acid protects against doxorubicin-induced cardiotoxicity by activating the Nrf2/HO-1 signaling pathway. Phytomedicine. 106. 154407–154407. 62 indexed citations
14.
Chen, Liping, Qian Li, Jingwen Xie, et al.. (2019). Design and optimize N‐substituted EF24 as effective and low toxicity NF‐κB inhibitor for lung cancer therapy via apoptosis‐to‐pyroptosis switch. Chemical Biology & Drug Design. 94(1). 1368–1377. 28 indexed citations
15.
Li, Song, Chao Zhou, Heng Wang, et al.. (2019). Cisplatin induces chemoresistance through the PTGS2-mediated anti-apoptosis in gastric cancer. The International Journal of Biochemistry & Cell Biology. 116. 105610–105610. 29 indexed citations
16.
Liu, Tianchi, Xiaoping Wu, Tong Chen, Zewei Luo, & Xiaohua Hu. (2017). Downregulation of DNMT3A by miR-708-5p Inhibits Lung Cancer Stem Cell–like Phenotypes through Repressing Wnt/β-catenin Signaling. Clinical Cancer Research. 24(7). 1748–1760. 77 indexed citations
17.
Wu, Jianzhang, Shanshan Zhang, Song Yao, et al.. (2016). Design, synthesis, and evaluation of asymmetric EF24 analogues as potential anti-cancer agents for lung cancer. European Journal of Medicinal Chemistry. 125. 1321–1331. 38 indexed citations
18.
Huang, Zhifeng, Huiyan Wang, Xiaoping Wu, et al.. (2011). A Better Anti-Diabetic Recombinant Human Fibroblast Growth Factor 21 (rhFGF21) Modified with Polyethylene Glycol. PLoS ONE. 6(6). e20669–e20669. 44 indexed citations
19.
Chen, Zhongjia, Qingchuan Zhang, Zhenyu Jiang, Huifeng Jiang, & Xiaoping Wu. (2009). A Macroscopic Model for the Portevin-Le Chatelier Effect. Journal of Material Science and Technology. 20(5). 535–539. 8 indexed citations
20.
Huang, Zhifeng, Qing Zheng, Xiaoping Wu, et al.. (2007). Enhanced protection of modified human acidic fibroblast growth factor with polyethylene glycol against ischemia/reperfusion-induced retinal damage in rats. Toxicology Letters. 170(2). 146–156. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026